Physician Wealth Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$439K Buy
1,013
+74
+8% +$22.5K 0.05% 127
2026
Q1
$201K Buy
939
+175
+23% +$39.1K 0.03% 191
2025
Q4
$131K Buy
764
+249
+48% +$38.7K 0.02% 239
2025
Q3
$69K Buy
515
+460
+836% +$48.7K 0.01% 318
2025
Q2
$5.35K Buy
55
+27
+96% +$2.14K ﹤0.01% 779
2025
Q1
$2.04K Buy
28
+13
+87% +$1.02K ﹤0.01% 865
2024
Q4
$1.08K Buy
+15
New +$1.14K ﹤0.01% 927

Other funds holding LRCX

Physician Wealth Advisors's LRCX Position: Q2 2026 in Review

Physician Wealth Advisors increased its Lam Research (LRCX) stake by 7.9% in Q2 2026, buying an estimated $22.5K and bringing the position to 1,013 shares worth $439K. The position accounts for 0.05% of the portfolio, ranked #127.

Physician Wealth Advisors first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 1,507 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Physician Wealth Advisors held 1,013 shares of Lam Research worth $439K as of Q2 2026.
  • Physician Wealth Advisors bought 74 Lam Research shares in Q2 2026, an estimated $22.5K.
  • Lam Research made up 0.05% of Physician Wealth Advisors's portfolio in Q2 2026, its #127 holding.
  • Physician Wealth Advisors first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 1,507 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.